In addition to the germline mutation in TP53, the DNA analysis revealed somatic stopgain mutations in the TSC2 and NF1 tumor suppressor genes, as well as a stopgain mutation in GPS2 (Figure 2B). The gene discussed is GPS2; the disease is neoplasm.